Evidence map›Paper›PMID 29983529›Full record

ArticleEthiopian journal of health sciences2018

Mutations of

Ashraf Tavanaee Sani, Habib Ashna, Afsaneh Kaffash, Azad Khaledi, Kiarash Ghazvini

Abstract read
In one paragraph

Article in Ethiopian journal of health sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Frontiers in microbiology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashraf Tavanaee SaniInfectious Diseases Department, Mashhad University of Medical Sciences, Mashhad, Iran.
Habib AshnaInfectious Diseases Department, Mashhad University of Medical Sciences, Mashhad, Iran.
Afsaneh KaffashInfectious Diseases Department, Mashhad University of Medical Sciences, Mashhad, Iran.
Azad KhalediInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, IR Iran.
Kiarash GhazviniAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug resistance is a leading concern in control of TB. Resistance against rifampin as one of the most important drugs in the treatment of

methodsThis study was conducted on referred samples of patients who did not respond to anti-TB treatment, in Tuberculosis Regional Reference Laboratory at Shariati Hospital. Drug susceptibility of M. tuberculosis isolates was surveyed using a proportional method on LJ medium. The isolates with resistant to rifampin were reconfirmed and then the rpoB gene was amplified and sequenced.

resultsAmong 27 resistant cases, 8, 11 and 8 people were from Iran, Afghanistan, and Turkmenistan, respectively. In 26 out of 27 isolates, rpoB gene mutations were observed. The most prevalent mutations belonged to the codon 53.

conclusionThe use of rpoB gene sequencing led to the lack of the need for growth of the organism in the culture medium, the direct use of clinical samples, reduction of biological risks and a detection about 96.3% of MDR TB cases lowering the cost of the treatment.

Indexed as

Drug Resistance, BacterialMutationAdultAntitubercular AgentsBacterial ProteinsCodonDNA-Directed RNA PolymerasesFemaleGenes, BacterialHumansIranMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisRifampinAntitubercular AgentsBacterial ProteinsCodonDNA-Directed RNA PolymerasesRifampinrpoB protein, Mycobacterium tuberculosisDrug-resistantMycobacterium tuberculosisRifampicinrpoB gene

Identifiers

PMID29983529
PMCPMC6016358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.